Enter the genotypes from your existing pharmacogenetic test and get a Gene2Rx Panel Report: every covered medication interpreted against current CPIC, FDA, and DPWG guidance, not just the ones on your original report.
Pick the two star alleles for each gene on your report, such as CYP2D6 *1/*4.
See which medications your results cover before you pay.
Your Panel Report is ready in your account within minutes, as a web page and a PDF.
You need each gene's genotype: two star alleles such as CYP2C19 *1/*2. Most reports list them in a gene results or genotype section, often near the end. A label like "intermediate metabolizer" or a medication color is an interpretation of the genotype and isn't enough on its own.
Step-by-step help: GeneSight reports · Genomind reports · Reading any PGx report
These cover most of the drug-metabolism genes on GeneSight, Genomind, and clinical PGx panel reports. CYP2D6 duplications (such as *2xN) and tandems (such as *36+*10) are supported.
You can also enter ABCG2, ADH1B, AKT1, ALDH2, BCHE, CACNA1S, CHRNA5, CYP2A6, FAAH, GIPR, GLP1R, IFNL3, NAT2, RYR1, SULT1A1, including single-variant results such as rs4680 G/A. Results reported only as a phenotype or a color category can't be entered, and genes such as HLA, MTHFR, SLC6A4, and HTR2A aren't supported. Medications that depend only on genes you don't enter won't be in your report.
$19 one time
Commercial panels focus on the medications they were ordered for. Gene2Rx interprets your genotypes against every medication in its guideline set, so the same results often cover many more drugs. With Gene2Rx Pro, your report is also updated as the guidelines change.
Usually, but not always. Gene2Rx applies published CPIC, FDA, and DPWG guidance, and labs sometimes use their own classifications. A difference doesn't mean either report is wrong; discuss it with your clinician.
No. We check that each genotype is one we can interpret, but we never see your laboratory report, so copy your results carefully. If you mistype a genotype, you can correct it later at no charge.
Raw data files cover more genes, so a report from your file is usually more complete. See our raw-data reports.
GeneSight and Genomind are trademarks of their respective owners. Gene2Rx is independent and is not affiliated with or endorsed by either company.